Glecaprevir/pibrentasvir - AbbVie
At a glance
- Drug Originator AbbVie; Enanta Pharmaceuticals
- Drug Class Antivirals; Aza compounds; Benzimidazoles; Carbamates; Cyclic ethers; Cyclopentanes; Cyclopropanes; Fluorobenzenes; Piperidines; Pyrrolidines; Quinoxalines; Small molecules
- Mechanism of Action Hepatitis C virus NS 5 protein inhibitors; Hepatitis C virus NS3 protein inhibitors; Hepatitis C virus NS4 protein inhibitors
- USA Patent Applicants ABBVIE
- USA Patents 18
- NDAs 2
- International Patents 541
Table of Contents
Disclaimer